Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
| Image |  |
|---|---|
| Description | scientific article published on 19 December 2016 |
| Author/s |
author: Ingeborg A Hauser Corrado Tarella Gregor Verhoef Ulrich Dührsen Sylvain Choquet Eric Van Den Neste Peter Mollee Jan Maciej Zaucha Marion Subklewe Heiner Zimmermann Olivier Gheysens Franck Morschhauser Thomas Tousseyn Gilles Salles Ralf Trappe Andreas Hüttmann Hanno Riess Petra Reinke |
| Publication date | December 19, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |